OcuTerra Therapeutics

company

About

OcuTerra Therapeutics is developing novel eye drop designed to treat diabetic eye disease.

Details

Last Funding Type
Series B
Last Funding Money Raised
$35M
Industries
Biotechnology,Therapeutics
Founded date
Jan 1, 2011
Number Of Employee
11 - 50
Operating Status
Active

OcuTerra Therapeutics, Inc. is developing innovative drugs for ophthalmic diseases for which the current standard of care does not prevent or control the progression of the disease.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$35M
OcuTerra Therapeutics has raised a total of $35M in funding over 2 rounds. Their latest funding was raised on Nov 9, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 9, 2021 Series B $35M Detail
Jun 8, 2021 Series B 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
OcuTerra Therapeutics is funded by 1 investors. Robin Hood Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Robin Hood Ventures Series B

Employee Profiles

Number of Employee Profiles
3
OcuTerra Therapeutics has 3 current employee profiles, including Executive Kerrie Brady
Executive
Executive
Executive